Early on-set of Dementia, Alzheimer’s Disease and other Degenerative Brain DisordersNow there is a tool for early diagnosis!
Alzheimer’s disease is a neuro-degenerative disease of the brain which leads to loss of memory and cognitive functions
In the early stages of Alzheimer’s, a patient may function independently. He or she may still drive, work and be part of social activities. Despite this, the patient may feel as if he or she is having memory lapses, such as forgetting familiar words, the location of everyday objects or the ability to navigate. At this stage of the disease, the patient is usually a self advocate, and when seeking consultation with non-specific neurological symptoms, a physician may not make a diagnosis (lack of availability of objective testing) and will not prescribe neuro-supportive pharmaceuticals. Patients at this early stage of the disease would greatly benefit from neuro-supportive pharmaceuticals to maintain quality of life and greatly delay onset of very harsh late stage of the disease.
Without Intellig-EYES™ diagnosis is usually not made until the disease has progressed to a more critical point (point of no return).
an objective test can be utilized by physicians when a patient is still a self advocate and has non-specific neurological symptoms. Early diagnosis and prescribing neuro-supportive pharmaceuticals may greatly extend the patient’s quality of life and greatly delay onset of very harsh late stage of the disease.
usually no diagnosis is made until progression of the disease has reached a more critical point (point of no return) when friends, family or neighbors begin to notice difficulties. During a detailed subjective medical interview, a physician may be able to detect problems in memory or concentration.
The market opportunity for tools to detect concussions, TBI and Alzheimer’s is enormous! Many years and dollars have been invested in the creation of our device, Intellig-EYES™, and it is the first of its kind in the detection of brain performance anomalies.
Axon Medical Technologies, LLC
Be part of cutting edge technology and be in the forefront of developing tools to quantify and document brain health. Be a part of its continuing development and adoption in the market.